Eva Rossmann

Do creative people use shorter associative pathways?

Eva Rossmann, Andréas Fink · Personality and Individual Differences · 2010 · 132 citations

Behavioral Sciences, Cognitive Science, Creative Computing +8

Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia

Jeanette Lundin, Anna Porwit‐MacDonald, Eva Rossmann et al. · Leukemia · 2004 · 118 citations

Hematological Malignancy, Lymphoid Neoplasia, Subcutaneous Alemtuzumab +11

Durable Carcinoembryonic Antigen (CEA)-Specific Humoral and Cellular Immune Responses in Colorectal Carcinoma Patients Vaccinated with Recombinant CEA and Granulocyte/Macrophage Colony-Stimulating Factor

Gustav Ullenhag, Jan‐Erik Frödin, Mahmood Jeddi‐Tehrani et al. · Clinical Cancer Research · 2004 · 90 citations

RG6234, a GPRC5DxCD3 T-Cell Engaging Bispecific Antibody, Is Highly Active in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Intravenous (IV) and First Subcutaneous (SC) Results from a Phase I Dose-Escalation Study

Carmelo Carlo‐Stella, Rita Mazza, Salomon Manier et al. · Blood · 2022 · 86 citations

Variability in B-cell antigen expression: implications for the treatment of B-cell lymphomas and leukemias with monoclonal antibodies

Eva Rossmann, Jeanette Lundin, Rodiça Lenkei et al. · The Hematology Journal · 2001 · 81 citations

Hematological Malignancy, Lymphoid Neoplasia, Malignant Blood Disorder +11